Shell Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Shell Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,262	Closed	-$100K	–	1280
2023 Q3	$100K	Sell	23,262 -363	-2%	-$2.02K	﹤0.01%	1087
2023 Q2	$156K	Sell	23,625 -6,899	-23%	-$44.2K	0.01%	1002
2023 Q1	$207K	Sell	30,524 -108	-0.4%	-$759	0.01%	912
2022 Q4	$226K	Sell	30,632 -6,423	-17%	-$62.6K	0.01%	912
2022 Q3	$366K	Sell	37,055 -9,712	-21%	-$103K	0.01%	732
2022 Q2	$510K	Buy	46,767 +79	+0.2%	+$819	0.02%	708
2022 Q1	$528K	Sell	46,688 -6,909	-13%	-$90.8K	0.01%	789
2021 Q4	$841K	Buy	53,597 +244	+0.5%	+$4.25K	0.02%	648
2021 Q3	$914K	Sell	53,353 -2,300	-4%	-$40.3K	0.02%	550
2021 Q2	$1.2M	Buy	55,653 +11,753	+27%	+$210K	0.02%	496
2021 Q1	$659K	Buy	43,900 +12,068	+38%	+$195K	0.01%	731
2020 Q4	$418K	Buy	31,832 +21,840	+219%	+$263K	0.01%	877
2020 Q3	$97K	Hold	9,992	–	–	﹤0.01%	1176
2020 Q2	$114K	Buy	+9,992	New	+$113K	﹤0.01%	1132
2017 Q4	–	Sell	-30,168	Closed	-$540K	–	1124
2017 Q3	$540K	Sell	30,168 -700	-2%	-$11.7K	0.01%	845
2017 Q2	$503K	Hold	30,868	–	–	0.01%	905
2017 Q1	$432K	Sell	30,868 -2,160	-7%	-$30.8K	0.01%	940
2016 Q4	$527K	Buy	+33,028	New	+$531K	0.01%	861

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Shell Asset Management's VNDA Position: Q4 2023 in Review

Shell Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 23,262 shares — an estimated $100K sold.

Shell Asset Management first reported a position in VNDA in Q4 2016 and held it in 18 quarters. The position peaked at $1.2M in Q2 2021. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.

Shell Asset Management reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Shell Asset Management sold 23,262 Vanda Pharmaceuticals shares in Q4 2023, an estimated $100K.
Shell Asset Management first reported a position in Vanda Pharmaceuticals in Q4 2016 and held it in 18 quarters.
Shell Asset Management's Vanda Pharmaceuticals position peaked at $1.2M in Q2 2021.
157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.

Based on Shell Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.